4D Molecular Therapeutics, Inc. reports

Company location: Emeryville, CA
Fiscal year end: 31 December

4D Molecular Therapeutics, Inc. has filed 435 SEC EDGAR filings since 13 Aug 2015

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 276-300 of 435 matching filings.

Per page

25

Current page

12

4

FORM 4

Filing date: 14 Feb 2023
Reporting date: 10 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 14 Feb 2023
Reporting date: 10 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A filing

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

JHI PLC OWNS <5%

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A

Filing date: 08 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39782

8-K

Filing date: 03 Feb 2023
Reporting date: 02 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-91921

SC 13G/A filing

Filing date: 31 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39782

8-K

Filing date: 26 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jan 2023
Reporting date: 19 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 22 Dec 2022
Reporting date: 21 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 19 Dec 2022
Reporting date: 15 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Dec 2022
Reporting date: 01 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39782

8-K

Filing date: 09 Nov 2022
Reporting date: 09 Nov 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-39782

10-Q

Filing date: 08 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 27 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-39782

8-K

Filing date: 27 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

EFFECT File 333-267013

EFFECT filing

Filing date: 06 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 01 Sep 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 30 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .